Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...

Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

As we approach the 10th anniversary of the amendment to Federal Rule of Civil Procedure 26(b)(1), which called for “proportionality” of discovery requests and responses, it is appropriate to provide ...

The president threatened to “deploy every tool” in the administration’s arsenal if drug companies don’t cut certain prices by ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Earnings watch - Notable companies due to report include Palantir Technologies ( PLTR ), MercadoLibre ( MELI ), Wayfair ( W ) ...

On Stocktwits, retail sentiment around Pheton is trending in the ‘extremely bullish’ territory, coupled with ‘extremely high’ ...

Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...

Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and ...

Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

The letters demand US drug prices match or undercut global lows, triggering a 60-day compliance timeline, and prompting ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.